UrologistMayo Clinic, United States
MP-04.04: Encore Durability Results From Bond-003 Cohort C- Phase 3, Single-Arm Study of Intravesical Cretostimogene Grenadenorepvec for High-Risk BCG-Unresponsive Non-Muscle Invasive Bladder Cancer with Carcinoma in Situ
Friday, October 31, 202508:00 - 09:00 GMT+0
